Celera Closes $33M Atria Acquisition | GenomeWeb
NEW YORK (GenomeWeb News) — Celera today said it has closed its $33 million acquisition of Atria Genetics, a maker of human leukocyte antigen-testing products used in organ donor matching.
 
Celera said it plans to integrate all of Atria’s 13 employees into its company.
 
Celera also said it expects the acquisition will be accretive to its earnings by the second half of 2008.
 
The company disclosed its plans to buy the South San Francisco, Calif.-based company last month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.